Home › Alexion Receives Notification of PDUFA Date Extension for Kanuma ...
 

Keywords :   


Alexion Receives Notification of PDUFA Date Extension for Kanuma ...

2015-09-04 23:15:02| Biotech - Topix.net

Alexion Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration has extended the Prescription Drug User Fee Act date for its Priority Review of the Company's Biologics License Application for Kanuma a , an investigational enzyme replacement therapy for the treatment of lysosomal acid lipase deficiency . The previously disclosed September 8, 2015 PDUFA date has been extended by the standard extension period of three months.

Tags: date extension notification receives

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
06.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Forecast Discussion Number 9
05.11Tropical Storm Rafael Wind Speed Probabilities Number 9
05.11Tropical Storm Rafael Public Advisory Number 9
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Forecast Advisory Number 9
05.11Delayed implementation of EID eartag rule requested
More »